These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 3731677)
1. Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine. Carrum G; Egan JM; Abernethy DR Clin Pharmacol Ther; 1986 Aug; 40(2):140-3. PubMed ID: 3731677 [TBL] [Abstract][Full Text] [Related]
2. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates. Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276 [TBL] [Abstract][Full Text] [Related]
3. Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy. Bauer LA; Stenwall M; Horn JR; Davis R; Opheim K; Greene L Clin Pharmacol Ther; 1986 Aug; 40(2):239-42. PubMed ID: 3731687 [TBL] [Abstract][Full Text] [Related]
4. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione. Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736 [TBL] [Abstract][Full Text] [Related]
5. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans. Abernethy DR; Egan JM; Dickinson TH; Carrum G J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045 [TBL] [Abstract][Full Text] [Related]
6. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine. Bottorff MB; Lalonde RL; Kazierad DJ; Hoon TJ; Tsiu SJ; Mirvis DM Pharmacotherapy; 1989; 9(5):315-21. PubMed ID: 2510135 [TBL] [Abstract][Full Text] [Related]
7. Accuracy and clinical utility of simplified tests of antipyrine metabolism. Farrell GC; Zaluzny L Br J Clin Pharmacol; 1984 Oct; 18(4):559-65. PubMed ID: 6487495 [TBL] [Abstract][Full Text] [Related]
8. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486 [TBL] [Abstract][Full Text] [Related]
9. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man. Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715 [TBL] [Abstract][Full Text] [Related]
10. Impairment of antipyrine clearance in humans by propranolol. Greenblatt DJ; Franke K; Huffman DH Circulation; 1978 Jun; 57(6):1161-64. PubMed ID: 639239 [TBL] [Abstract][Full Text] [Related]
11. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980 [TBL] [Abstract][Full Text] [Related]
12. Effects of diltiazem on plasma level and urinary excretion of digoxin in healthy subjects. Yoshida A; Fujita M; Kurosawa N; Nioka M; Shichinohe T; Arakawa M; Fukuda R; Owada E; Ito K Clin Pharmacol Ther; 1984 May; 35(5):681-5. PubMed ID: 6713780 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the effects of isradipine and diltiazem on antipyrine and indocyanine green clearances in elderly volunteers. Klockowski PM; Lener ME; Sirgo MA; Rocci ML Clin Pharmacol Ther; 1990 Oct; 48(4):375-80. PubMed ID: 2146057 [TBL] [Abstract][Full Text] [Related]
14. Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol. Staiger C; Schlicht F; Walter E; Gundert-Remy U; Hildebrandt R; de Vries J; Wang NS; Harenberg J; Weber E Eur J Clin Pharmacol; 1983; 25(6):797-801. PubMed ID: 6141054 [TBL] [Abstract][Full Text] [Related]
15. Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepam. Abernethy DR; Greenblatt DJ; Eshelman FN; Shader RI Clin Pharmacol Ther; 1984 Feb; 35(2):188-92. PubMed ID: 6319067 [TBL] [Abstract][Full Text] [Related]
16. Effects of nifedipine on hepatic drug oxidation. Dickinson TH; Egan JM; Abernethy DR Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161 [TBL] [Abstract][Full Text] [Related]
18. Physical exercise and improvement of liver oxidative metabolism in the elderly. Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268 [TBL] [Abstract][Full Text] [Related]
19. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers. Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285 [TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the effects of labetalol, verapamil and diltiazem on antipyrine and indocyanine green clearances. Rocci ML; Vlasses PH; Lener ME; Fruncillo RA; Sirgo MA J Clin Pharmacol; 1989 Oct; 29(10):891-5. PubMed ID: 2592580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]